États-Unis · Plateformes & données · Yahoo Finance

Bristol Myers (BMY) Has New Cancer Wins. Can They Offset the Patent Cliff?

Publié par Yahoo Finance · États-Unis il y a 10 h

Drug Problem Bristol-Myers Squibb Company (NYSE:BMY) reported positive data from its radiopharmaceutical RYZ101 Phase III ACTION-1 trial and additional progress across multiple…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

Bristol Myers (BMY) Has New Cancer Wins. Can They Offset the Patent Cliff?

À lire aussi

Alcoa (NYSE:AA) Stock Gets Price Target Trim from Citigroup

Equifax: 3 Key Takeaways for Long-Term Investors

One consortium moves ahead in the GFL Environmental sales process - CTFN (update)

Here’s what matters most to Tesla investors heading into earnings

US Tiger Securities reiterates buy on Coinbase stock, cites Bitcoin rebound

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Bristol Myers (BMY) Has New Cancer Wins. Can They Offset the Patent Cliff?

Partager

À lire aussi

Alcoa (NYSE:AA) Stock Gets Price Target Trim from Citigroup

Equifax: 3 Key Takeaways for Long-Term Investors

One consortium moves ahead in the GFL Environmental sales process - CTFN (update)

Here’s what matters most to Tesla investors heading into earnings

US Tiger Securities reiterates buy on Coinbase stock, cites Bitcoin rebound

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030